| Affecting Drugs | |
|---|---|
| Drug Name | PubMed Articles (year of publication) |
| 5-phenyl-1H-pyrazol-3-yl)-[4-(p-tolylsulfonyl)piperazin-1-yl]-methanone | |
| D-cycloserine | |
| N-(3-bicyclo[2.2.1]heptanyl)-4-(3-fluoro-4-methoxyphenyl)-N-[[4-[5-[[2-(4-methylsulfonylphenyl)ethylamino]methyl]pyridin-2-yl]phenyl]methyl]-4-oxobutanamide | |